Want to join the conversation?
$MA 2Q15 Q&A: On a question asked by Jeffrey of SunTrust about acquisition approach, Martina answered that from a strategic point of view, MA has got more clarity over last 4-5 years in terms of where it want to strategically play. Will be looking at area of strategic importance for acquisition and are giving cash back to shareholders; no change.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.